News & Analysis as of

Investment Healthcare

Ballard Spahr LLP

The Future of Life Sciences Facilities

Ballard Spahr LLP on

The life science real estate market is undergoing a period of adjustment in 2025, marked by ups and downs in different segments of the life science sector. Following the frenetic pace of recent years, the market has cooled...more

Ballard Spahr LLP

Trends In Dealmaking

Ballard Spahr LLP on

As the page turned on 2025, optimism was high among life sciences dealmakers. Elections in the U.S. and other major economies had concluded, interest rates were poised to come in to focus, and the regulatory environment...more

McGuireWoods LLP

Frontiers in Women’s Health: Where Investor Opportunities Meet Unmet Need

McGuireWoods LLP on

For years, women’s health was often siloed into OB/GYN care and absent from mainstream investment theses, but that landscape is changing. New platforms and care models are addressing women’s health in a more comprehensive...more

Ropes & Gray LLP

Artificial Intelligence H1 2025 Global Report: Deal trends, fundraising, segment highlights, and market outlook

Ropes & Gray LLP on

Despite uncertainty in global markets, AI remains a strategic priority among business executives, investors, and government, fueling sustained investment in AI infrastructure and dealmaking with AI developers and AI-enabled...more

Spilman Thomas & Battle, PLLC

Decoded - Technology Law Insights, V 6, Issue 7, July 2025

Welcome to our seventh issue of 2025 of Decoded - our technology law insights e-newsletter. What does the US GENIUS Act Mean for Stablecoins? “The White House categorically states it is a historic piece of legislation that...more

Cozen O'Connor

Pennsylvania Perspective for Thursday, July 17, 2025

Cozen O'Connor on

PA Budget Bill Passes in House, Stalls in Senate - On Monday, the Democratic-led state House voted to forward their state budget bill to the Senate, where GOP leadership is skeptical of full passage. While the House’s...more

A&O Shearman

A new European strategy to foster life sciences innovation and market access

A&O Shearman on

On July 2, 2025, the European Commission released its communication “Choose Europe for life sciences. A strategy to position the EU as the world’s most attractive place for life sciences by 2030” (the Strategy). ...more

MoFo Life Sciences

Key Developments in MedTech M&A: Momentum Despite Macroeconomic Uncertainty

MoFo Life Sciences on

2024 was a challenging year for M&A activity in the medical technology (“MedTech”) industry. Although some sectors experienced a rebound in deal volume, MedTech dealmakers were disproportionately affected by a difficult...more

Fenwick & West LLP

The Buzz Around Femtech at New York Tech Week 2025

Fenwick & West LLP on

The femtech sector's evolution presents opportunities for tech, healthcare, and life sciences companies that are both vast and largely untapped. What began as a narrow focus on period-tracking applications has blossomed into...more

Fenwick & West LLP

NY Tech Week 2025: The Future of Femtech

Fenwick & West LLP on

Femtech stands at an exciting inflection point. What was initially perceived as a niche category focused on period-tracking apps has evolved into a comprehensive ecosystem addressing women's health needs with individualized...more

K&L Gates LLP

Shareholder Disputes in Medical and Dental Practices in Australia

K&L Gates LLP on

Key Takeaways - Shareholder disputes arise from circumstances both anticipated and unanticipated at the time of formation of a business relationship....more

King & Spalding

Oregon Enacts Further Restrictions Against Private Equity Investment in Medical Practices

King & Spalding on

Last week, Oregon enacted into law SB951, which strengthens Oregon’s corporate practice of medicine doctrine by implementing greater restrictions on arrangements between medical practices and management services organizations...more

Rivkin Radler LLP

Tennr’s AI Platform Targets Referral “Black Holes” with $101 Million in New Funding

Rivkin Radler LLP on

Tennr, a healthcare technology company focused on streamlining healthcare operations, recently announced the receipt of $101 million in funding. While the investment signals growing confidence in AI-enabled administrative...more

Rivkin Radler LLP

Digital Health Startup Raises $45M to Expand AI Care Manager Tool

Rivkin Radler LLP on

Ellipsis Health, a digital health startup based in San Francisco, recently announced that it raised $45 million in a Series A-1 funding round led by Salesforce Ventures, CVS Health Ventures, and Khosla Ventures. The funding...more

McGuireWoods LLP

Healthcare & Life Sciences Private Equity Deal Tracker: Great Point Acquires Eutecma

McGuireWoods LLP on

Great Point Partners (GPP) has announced the acquisition of a majority stake in Eutecma. Eutecma, founded in 2008 and based in Germany, is a developer of temperature-controlled packaging solutions for pharmaceutical cold...more

Cozen O'Connor

Pennsylvania Perspective for Thursday, June 12, 2025

Cozen O'Connor on

Gov. Shapiro, Amazon Unveil Historic $20B AI Investment in PA - On Monday, Governor Josh Shapiro (D) and Amazon announced a $20 billion investment to build AI infrastructure in Pennsylvania, including two major data centers...more

Ropes & Gray LLP

What Are the Key Takeaways From Rachel Reeves’ Spending Review and Who Will be the Biggest Winners?

Ropes & Gray LLP on

Rachel Reeves, the UK’s Chancellor of the Exchequer, has revealed the Government’s Spending Review 2025 (SR25) setting out departmental budgets until 2029 and capital investment until 2030. The SR25 is in line with the...more

Goodwin

Oregon Governor Signs Law Aggressively Restricting Private Equity Investment in Medical Practices

Goodwin on

*UPDATE* Oregon Senate Bill 951, described in the alert below originally published on May 30, 2025, was signed into law by Oregon Governor Tina Kotek on Monday, June 9, and will apply to all new investments beginning January...more

Wilson Sonsini Goodrich & Rosati

The Life Sciences Report – June 2025

This latest edition features articles on succeeding in the current life sciences funding market, strategic and legal considerations in digital health combinations, the corporate practice of medicine and guidance for...more

McDermott Will & Schulte

McDermott HealthEx 2025: McKinsey Key Takeaways

McDermott HealthEx convened more than 1,300 of the most influential leaders in healthcare and life sciences. The event emphasized creativity, transformation, and growth, with sessions dedicated to innovation, AI-powered...more

Foley & Lardner LLP

Rethinking University Research: Innovating the Innovation Ecosystem to Support Life Sciences and Personalized Medicine

Foley & Lardner LLP on

Personalized medicine—tailoring treatments to individual patients based on their genetic makeup, lifestyle, and environment—is transforming healthcare. But this revolution didn’t begin in the private sector. It was sparked...more

A&O Shearman

The future of the robotics metaverse in the healthcare sector

A&O Shearman on

On 26 February 2025, the European Economic and Social Committee (EESC) adopted an opinion addressing the integration of robotics and the metaverse in healthcare. This forward-looking document outlines the opportunities and...more

J.S. Held

Beyond Safety & Effectiveness: Business Reasons to Prioritize Human Factors in Medical Device Design

J.S. Held on

To err is human. We have short attention spans and get distracted easily. We have unreliable memories and forget. We have a limited ability to process information, and we overgeneralize rules-of-thumb to the wrong situations....more

Bennett Jones LLP

BBHIC 2025: Key Insights From Canada’s Leading Healthcare Investment Conference

Bennett Jones LLP on

The Bloom Burton & Co. Healthcare Investor Conference (BBHIC), held in Toronto this week, drew over 1,500 global participants to one of Canada's leading events for healthcare investment and innovation. The conference brought...more

Benesch

Dental/DSO Intelligence Monthly Report: April 2025

Benesch on

DSOs have experienced several challenges amid the slowing private equity space in the years since the COVID-19 pandemic and the tightening of the private equity space, however, there are signs of a shift, with a number of...more

227 Results
 / 
View per page
Page: of 10

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide